|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
35.180 +0.800 (+2.327%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 596,055 | 29.275% | 461,075 | 392,322 | 339,764 | 225,217 |
| Cost of Sales | (231,676) | 21.670% | (190,414) | (145,554) | (139,414) | (101,194) |
| Gross Profit | 364,379 | 34.626% | 270,661 | 246,768 | 200,350 | 124,023 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (3,699) | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | 481 | (637) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | (585) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 144,683 | 19.863% | 120,707 | 110,749 | 88,417 | 56,829 | |
| Taxation | (19,014) | 4.067% | (18,271) | (11,571) | (7,912) | (6,704) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (15,345) | 292.656% | (3,908) | 1,360 | (3) | 716 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 110,324 | 11.972% | 98,528 | 100,538 | 80,502 | 50,841 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (9,700) | 259.926% | (2,695) | (3,216) | (5,073) | (5,291) |
| Depreciation & Amortisation | 58,501 | 31.682% | 44,426 | 42,134 | 20,911 | 17,374 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 54.000 | -5.263% | 57.000 | 58.000 | 48.000 | 31.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 13.048 | -- | 10.659 | 9.538 | 9.253 | 8.506 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 110,324 |
| %Change | 11.972% |
| EPS / (LPS) | RMB 0.540 |
| NBV Per Share (¥) | RMB 13.048 |